Fercy Warning Letter Confirms OTC Monograph Fears
This article was originally published in The Gold Sheet
Drug maker in China found to exploit gap in U.S. regulatory system, exporting OTC monograph drugs without key quality controls or registration until FDA inspection led to import suspension.
You may also be interested in...
Singapore recalls trigger international reaction as metformin is added to growing list of chronic medications found to contain NDMA.
Draft recommendation offers path to ICH Q12 regulatory relief.